Key Trends Reshaping the Neonatal Point Of Care Testing Market: Strategic Collaborations Driving Expanded Access And Faster Diagnostics In Newborn Health Industry Transformation

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Neonatal Point Of Care Testing Market Size Growth Forecast: What to Expect by 2025?
Over recent years, the market size for neonatal point of care testing has seen significant growth. It is expected to increase from $1.16 billion in 2024 to $1.32 billion in 2025, with a compound annual growth rate (CAGR) of 14.6%. Reasons for growth during the past period include a rise in neonatal disorder cases, accelerated need for quick diagnostic results, heightened awareness of neonatal health hazards, an increase in premature births, and the expanding adoption of bedside testing in hospitals.

How Will the Neonatal Point Of Care Testing Market Size Evolve and Grow by 2029?
The market size of neonatal point of care testing is projected to witness an impressive growth in the forthcoming years, reaching $2.27 billion by 2029 with a CAGR of 14.4%. This projected growth during the forecast period is chiefly due to the escalating demand for personalized care specifically for neonates, increased utilization of portable testing instruments, an upward trend in early detection of diseases, increased attention on lowering neonatal death rates, and augmented investment in sophisticated diagnostic equipment. Major trends set to drive this growth in the forecast period include enhancements in biosensor technology, innovative developments in microfluidic-based diagnostic platforms, financial commitment towards research and development of multiplex assays, progressive developments in wireless monitoring systems for neonates, and advances in point of care molecular testing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neonatal-point-of-care-testing-global-market-report

What Drivers Are Propelling the Growth of Neonatal Point Of Care Testing Market Forward?
The upsurge in the need for remote patient monitoring is predicted to fuel the expansion of the neonatal point of care testing market. Remote patient monitoring facilitates the delivery of medical services through technology, creating a bridge between patients and healthcare professionals, even from a distance. The requirement for this type of monitoring is continually growing, particularly to provide accessible and convenient medical care for patients in rural or underprivileged areas. Neonatal point-of-care testing aids this kind of monitoring by offering instant bedside diagnostic results, enabling medical providers to quickly detect and address serious conditions in newborns without depending on a central lab. As an illustration, a survey by Rock Health, a health technology firm from the US in February 2023, showed that out of 8,014 participants, 76% of individuals above the age of 55 have utilized telemedicine, and 80% of all participants reported having sought care through telemedicine at least once in their life. This was an increase of 8% from 72% in 2021. Thus, the escalating demand for remote patient monitoring is anticipated to boost the growth of the neonatal point of care testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28277&type=smp

Which Emerging Trends Are Transforming the Neonatal Point Of Care Testing Market in 2025?
Leading firms in the neonatal point of care testing market are concentrating their efforts on establishing strategic collaborations, which will enable them to penetrate new markets and reach a larger client base in a more effective manner. Such strategic partnerships involve companies pooling their resources and specializations to attain mutual business objectives. For example, QIAGEN, a company from the Netherlands that specializes in sample and assay technologies, initiated a collaboration with Genomics England, a genomic medicine business based in the UK, in January 2025. This collaboration has led to the initiation of the Generation Study which plans to sequence the genomes of 100,000 newborns in England with the aim of screening for over 200 treatable genetic conditions. QIAGEN will furnish crucial clinical variant data for the genes incorporated in the point-of-care sequencing test. This information will aid in a quicker interpretation and reporting of the sequencing results, thereby enabling faster detection and treatment of rare ailments. The study, which officially started in October 2024, is focused on conditions that are likely to affect approximately 3,000 newborns each year in the UK.

What Are the Key Segments in the Neonatal Point Of Care Testing Market?
The neonatal point of care testing market covered in this report is segmented as

1) By Product: Instruments, Assay
2) By Test Type: Neonatal Bilirubin Testing, Newborn Metabolic Screening, Blood Glucose Testing, Infectious Disease Screening, Electrolyte Testing, Other Test Types
3) By End-Users: Hospitals, Diagnostic Centers, Maternity And Specialty Clinics, Other End-Users

Subsegments:
1) By Instruments: Blood Gas Analyzers, Bilirubinometers, Glucose Meters, Hematology Analyzers, Multiparameter Monitors
2) By Assay: Bilirubin Assays, Glucose Assays, Infectious Disease Assays, Hematology Assays, Cardiac Marker Assays, Electrolyte Assays, Blood Gas Assays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28277&type=smp

Who Are the Key Players Shaping the Neonatal Point Of Care Testing Market's Competitive Landscape?
Major companies operating in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Konica Minolta Inc., Dräger Ag Co. Kg, Bio-Rad Laboratories Inc., Masimo Corporation, QIAGEN Inc., Radiometer Ltd., Contec Medical Systems Co. Ltd., Owen Mumford Ltd., Nova Biomedical, Heal Force Bio Meditech Holdings Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.I, GINEVRI srl, Hadleigh Health Technologies.

What Geographic Markets Are Powering Growth in the Neonatal Point Of Care Testing Market?
North America was the largest region in the neonatal point of care testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neonatal point of care testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28277

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.